Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Ondas Shares Surge 3.6% Premarket as $70M Orders Bolster Revenue Outlook
Ondas stock gained 3.6% premarket following a 19.4% weekly rally, as $70 million in new orders signal strong demand and raise execution expectations.
T3 Defense Stock Surges 39% Premarket on Project35 Deal Hopes
T3 Defense stock surged 39% in premarket trading as investors anticipate the closing of its Project35 acquisition, with the deal representing up to 78% of the company's implied equity.
Lloyds Shares Near Yearly High Ahead of Strategy Reveal and BOE Decision
Lloyds shares advanced 0.7% to 114.2p, closing in on a yearly high, as the market eyes a crucial strategy update and the BOE rate call. Consensus points to a first-half pretax profit of £4.12 billion.
Adrad Holdings Shares Dip on Thailand Plant Investment
Adrad Holdings (ASX:AHL) shares declined 0.8% as the company invests A$3 million in a new Thailand plant, with half-year revenue up 0.6% and EBITDA rising 13%.
QuantumScape Market Cap Drops $596M as PowerCo Payment Cap Falls 42%
QuantumScape shares tumbled 16.6% as PowerCo slashed its payment ceiling by 42%, erasing $596 million in market cap and underscoring concerns over battery commercialization.
Ondas Shares Surge 20% on $70M Orders, Revenue Conversion in Focus
Ondas shares surged 19.5% last week after $70 million in orders, representing 13.3% of the 2026 revenue goal of $525 million. The stock closed Friday at $7.80.
Joby Aviation Stock Drops 8% as Virgin Atlantic Deal Lacks Financial Details
Joby Aviation shares slid 8.1% on Friday, closing at $6.93, as the Virgin Atlantic agreement lacked specifics on aircraft orders, payments, or launch dates.
CSL Shares Slide 7.4% as HEMGENIX Scale-Up Faces Supply Constraints
CSL shares dropped 7.4% last week as HEMGENIX gene therapy progress remains limited, with supply constraints and revenue concerns weighing on the stock.
CBA Shares Rise as Competitors Outperform in Rate-Driven Rally
CBA shares rose 1.0% on Friday, trailing rivals Westpac, NAB, and ANZ which averaged a 1.41% gain as investors sought cheaper income plays.